Note: Ingredients listed on restricted chemical lists
EC/CAS
203-726-8/109-99-9
Name of the chemical
Tetrahydrofuran (618/2012)
Concentration
≥99% ≥25% ≥25%
General Information
Version
3
Revision date
2023-03-29
Product name
Danopol PVC líquido Light Grey
1.2.1 Relevant identified uses
(main technical functions)
Icons in SDS
Company Information
company name
DANOSA - DERIVADOS ASFÁLTICOS NORMALIZADOS, S.A
e-mail address of the competent person responsible for the Safety Data Sheet
info@danosa.com
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H225, H302, H319, H335, H351
Hazard statements
Code
Statements
H225
Highly flammable liquid and vapour
H302
Harmful if swallowed
H319
Causes serious eye irritation
H335
May cause respiratory irritation
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification of mixtures is carried out in accordance with the following principles: a) when data (tests) for the classification of mixtures are available, generally is carried out based on these data, b) in the absence of data (tests) for mixtures are generally used interpolation or extrapolation methods of assessing the risk, using the available data for mixtures similarly classified, and c) in the absence of tests and information which would allow to apply interpolation or extrapolation techniques, methods are used to classify risk assessment based on the data of the individual components in the mixture. Classification in accordance with Regulation (EU) No. 1272/2008~2021/849 (CLP): DANGER Flam. Liq. 2 H225|Acute Tox. (oral) 4 H302|Eye Irrit. 2 H319|Carc. 2 H351|STOT SE (irrit.) 3 H335|EUH019 Danger class Cat.
Principle Routes of Exposure
Target organs Effects Physicochemical: Flam. Liq. 2:H225 c) Cat.2 - EUH019:EUH019 c) - Human health: Acute Tox. (oral) 4:H302 c) Cat.4 Ingestion - Harmful Eye Irrit. 2:H319 c) Cat.2 Eyes Irritation Carc. 2:H351 c) Cat.2 - Cancer STOT SE (irrit.) 3:H335 c) Cat.3 Inhalation Respiratory tract Irritation
Environmental hazards
Not classified Full text of hazard statements mentioned is indicated in section 16. Note: When in section 3 a range of percentages is used, the health and environmental hazards describe the effects of the highest concentration of each component, but below the maximum value.
2.2 Label elements
This product is labelled with the signal word DANGER in accordance with Regulation (EU) No. 1272/2008~2021/849 (CLP)
Hazard statements
H225 Highly flammable liquid and vapour. H351 Suspected of causing cancer. H302 Harmful if swallowed. H319 Causes serious eye irritation. H335 May cause respiratory irritation. EUH019 May form explosive peroxides.
Precautionary statements
P102 Keep out of reach of children. P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P243 Take action to prevent static discharges. P337+P313 If eye irritation persists: Get medical advice/attention. P280 Wear protective gloves, clothing and eye protection. In case of inadequate ventilation wear respiratory protection. P301+P312 IF SWALLOWED: Call a POISON CENTER or doctor if you feel unwell. P303+P361+P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water [or shower] P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P305+P351+P338- IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. P310 Continue rinsing. Immediately call a POISON CENTER or doctor. P501 Dispose of contents/container to hazardous or special waste collection point.
Hazardous Ingredients
Tetrahydrofuran
Other physicochemical hazards
Vapours may form with air a mixture potentially flammable or explosive.
Potential health effects
Prolonged exposure to vapours may produce transient drowsiness. Prolonged contact may cause skin dryness.
Environmental effects
Does not contain substances that fulfil the PBT/vPvB criteria. Endocrine disrupting properties: This product does not contain substances with endocrine disrupting properties identified or under evaluation.